Bio­gen, Ei­sai’s Leqem­bi wins UK ap­proval, but not im­me­di­ate NHS cov­er­age

Bio­gen and Ei­sai’s Leqem­bi has been au­tho­rized by the UK’s Med­i­cines and Health­care prod­ucts Reg­u­la­to­ry Agency for Alzheimer’s dis­ease, but a neg­a­tive opin­ion from the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER